{"id":"isl","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Upper respiratory tract infection"}]},"_chembl":null,"_dailymed":{"setId":"afe2d7d6-7ce8-4115-b175-6ab39402eb79","title":"B PURE MOISTURIZING HAND SANITIZER PALM ISLAND BREEZE SCENTED (ALCOHOL) LIQUID [FOURSTAR GROUP USA, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ISL works by binding to ATP-sensitive potassium channels on pancreatic beta cells, causing depolarization and triggering insulin secretion. This mechanism helps lower blood glucose levels in patients with type 2 diabetes by enhancing endogenous insulin production in response to meals and elevated glucose concentrations.","oneSentence":"ISL is an insulin secretagogue that stimulates pancreatic beta cells to release insulin in response to glucose.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:17:18.256Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT04223791","phase":"PHASE3","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":643},{"nctId":"NCT07465354","phase":"NA","title":"OCD Summer Treatment Program for Adolescents in Iceland","status":"NOT_YET_RECRUITING","sponsor":"University of Iceland","startDate":"2026-05-01","conditions":"Obsessive-Compulsive Disorder (OCD)","enrollment":70},{"nctId":"NCT07452263","phase":"","title":"Modified Essential Frailty Toolset in Older Adults Undergoing Major Elective Surgery","status":"RECRUITING","sponsor":"University of Iceland","startDate":"2025-01-20","conditions":"Frailty in Adult Surgery, Frailty Syndrome, Elective Surgeries","enrollment":250},{"nctId":"NCT07086079","phase":"PHASE1","title":"A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-09-26","conditions":"Healthy","enrollment":12},{"nctId":"NCT04223778","phase":"PHASE3","title":"Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":672},{"nctId":"NCT05052996","phase":"PHASE2","title":"Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2021-10-05","conditions":"HIV-1 Infection","enrollment":142},{"nctId":"NCT04644029","phase":"PHASE3","title":"Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-02-24","conditions":"HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis","enrollment":730},{"nctId":"NCT07379359","phase":"NA","title":"The ADHD Kids´ Study for Children 9-12 Years of Age","status":"NOT_YET_RECRUITING","sponsor":"University of Iceland","startDate":"2026-01-02","conditions":"Attention-Deficit/Hyperactivity Disorder (ADHD)","enrollment":100},{"nctId":"NCT04233879","phase":"PHASE3","title":"Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-28","conditions":"HIV-1 Infection","enrollment":599},{"nctId":"NCT07367828","phase":"","title":"Validity of Frailty Screening Tools as a Measure for Postoperative Outcomes","status":"RECRUITING","sponsor":"University of Iceland","startDate":"2025-01-20","conditions":"Frailty in Adult Surgery, Frailty Syndrome, Elective Surgery","enrollment":350},{"nctId":"NCT04564547","phase":"PHASE2","title":"Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-03-09","conditions":"HIV-1 Infection","enrollment":161},{"nctId":"NCT07314593","phase":"NA","title":"Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.","status":"NOT_YET_RECRUITING","sponsor":"Landspitali University Hospital","startDate":"2025-12-19","conditions":"Respiratory Infections","enrollment":400},{"nctId":"NCT04776252","phase":"PHASE3","title":"Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-09-15","conditions":"HIV-1 Infection","enrollment":2000},{"nctId":"NCT05766501","phase":"PHASE3","title":"A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-03-17","conditions":"HIV Infection","enrollment":641},{"nctId":"NCT05631093","phase":"PHASE3","title":"A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-20","conditions":"HIV-1 Infection","enrollment":553},{"nctId":"NCT05630755","phase":"PHASE3","title":"A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-17","conditions":"HIV-1 Infection","enrollment":514},{"nctId":"NCT06630299","phase":"PHASE3","title":"Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-10-08","conditions":"HIV-1-Infection","enrollment":600},{"nctId":"NCT06630286","phase":"PHASE3","title":"Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-10-09","conditions":"HIV-1-infection","enrollment":609},{"nctId":"NCT05705349","phase":"PHASE3","title":"DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-03-08","conditions":"HIV-1 Infection","enrollment":537},{"nctId":"NCT06891066","phase":"PHASE2","title":"A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-14","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":150},{"nctId":"NCT03327597","phase":"NA","title":"Iceland Screens, Treats or Prevents Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Iceland","startDate":"2016-09-01","conditions":"Monoclonal Gammopathy of Undetermined Significance","enrollment":80761},{"nctId":"NCT07080476","phase":"NA","title":"Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.","status":"RECRUITING","sponsor":"Universiteit Antwerpen","startDate":"2025-08-25","conditions":"Breast Edema, Breast Cancer Related Lymphoedema, Breast Cancer Related Lymphedema","enrollment":128},{"nctId":"NCT04515641","phase":"PHASE1","title":"Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-11-05","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":12},{"nctId":"NCT05836688","phase":"NA","title":"A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-11-01","conditions":"Testicular Cancer","enrollment":250},{"nctId":"NCT06338475","phase":"NA","title":"A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2024-06-01","conditions":"Cancer","enrollment":100},{"nctId":"NCT06811246","phase":"PHASE1","title":"A Clinical Study of Islatravir and Its Interaction With Lamivudine (MK-8591-058)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-02-07","conditions":"Healthy","enrollment":20},{"nctId":"NCT04568603","phase":"PHASE1","title":"Islatravir and Methadone Pharmacokinetics (MK-8591-029)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-10-16","conditions":"HIV-1 Infection","enrollment":14},{"nctId":"NCT05849337","phase":"NA","title":"The Lóa Study: a Brief Digital Intervention for Women with Intrusive Memories in the SAGA Cohort","status":"RECRUITING","sponsor":"University of Iceland","startDate":"2023-10-30","conditions":"Intrusive Memories of Traumatic Event(s)","enrollment":380},{"nctId":"NCT04652700","phase":"PHASE3","title":"Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-03-15","conditions":"HIV Preexposure Prophylaxis","enrollment":494},{"nctId":"NCT04233216","phase":"PHASE3","title":"Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-03-18","conditions":"HIV-1 Infection","enrollment":35},{"nctId":"NCT06738914","phase":"","title":"Twenty Years of Pancreatic Surgery in Iceland","status":"COMPLETED","sponsor":"Linkoeping University","startDate":"2003-01","conditions":"Pancreatectomy, Pancreatoduodenectomy, Distal Pancreatectomy (DP)","enrollment":244},{"nctId":"NCT06719570","phase":"PHASE1","title":"A Study of Doravirine and Islatravir as a Single Entity or Combination Therapy and the Effect of Food in Healthy Adult Participants (MK-8591A-055)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-01-23","conditions":"Healthy","enrollment":24},{"nctId":"NCT06619678","phase":"PHASE1","title":"A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-01-17","conditions":"Healthy","enrollment":36},{"nctId":"NCT05469945","phase":"NA","title":"Lymphedema After Gyneco-oncologic Treatment","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-06-22","conditions":"Lymphedema, Genital Neoplasm","enrollment":218},{"nctId":"NCT06264323","phase":"","title":"Incidence of Acute Injuries in Boxing","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2017-09-01","conditions":"Injuries","enrollment":74},{"nctId":"NCT04295772","phase":"PHASE2","title":"Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-11-26","conditions":"HIV-1 Infection","enrollment":42},{"nctId":"NCT05115838","phase":"PHASE2","title":"Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)","status":"WITHDRAWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-01-04","conditions":"Human Immunodeficiency Virus, HIV","enrollment":""},{"nctId":"NCT05803447","phase":"","title":"Analysis of Parameters Indicating the Intensity of Suicidal Behavior in Psychiatric Patients","status":"COMPLETED","sponsor":"Medical University of Bialystok","startDate":"2016-09-01","conditions":"Suicidal Behaviour, Cognitive Functions Confusion","enrollment":120},{"nctId":"NCT04150120","phase":"NA","title":"eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness","status":"UNKNOWN","sponsor":"Lund University","startDate":"2019-10-15","conditions":"Preterm Birth, Pediatric Cancer, Hirschsprung Disease","enrollment":420},{"nctId":"NCT05089058","phase":"NA","title":"Lóa Project: An Exploratory Pilot Randomised Controlled Trial of a Remotely-delivered Brief Cognitive Intervention to Reduce Intrusive Memories of Trauma for Women in Iceland","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2021-11-01","conditions":"Intrusive Memories of Traumatic Event(s)","enrollment":13},{"nctId":"NCT05518344","phase":"NA","title":"Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers","status":"TERMINATED","sponsor":"Hanita Lenses","startDate":"2020-06-04","conditions":"Myopia","enrollment":4},{"nctId":"NCT01491815","phase":"PHASE4","title":"Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction","status":"UNKNOWN","sponsor":"Karolinska Institutet","startDate":"2012-12-14","conditions":"Rheumatoid Arthritis","enrollment":812},{"nctId":"NCT02466581","phase":"PHASE4","title":"Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity","status":"UNKNOWN","sponsor":"Karolinska Institutet","startDate":"2015-02-03","conditions":"Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT03995303","phase":"NA","title":"HOMEFOOD Study - Home Delivered Food and Nutrition Therapy for Discharged Geriatric Hospital Patients","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2019-01-01","conditions":"Malnutrition","enrollment":106},{"nctId":"NCT03991286","phase":"NA","title":"The Effect of Astaxanthin on Oxidative Stress Indices in Patients With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2020-01-20","conditions":"PCOS","enrollment":48},{"nctId":"NCT02586571","phase":"","title":"Growth and Body Composition in Breastfed Infants - Study on Age of Introduction of Complementary Foods in Iceland","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2014-12","conditions":"Adiposity, Body Composition, Beneficial, Growth Acceleration","enrollment":100},{"nctId":"NCT02647879","phase":"","title":"Treatment as Prevention for Hepatitis C in Iceland","status":"RECRUITING","sponsor":"Landspitali University Hospital","startDate":"2016-01","conditions":"Hepatitis C","enrollment":1000},{"nctId":"NCT04546191","phase":"","title":"Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland","status":"COMPLETED","sponsor":"Landspitali University Hospital","startDate":"2020-07-01","conditions":"Covid19","enrollment":1580},{"nctId":"NCT04544384","phase":"","title":"Acute Myocardial Infarction in Iceland, is There a Gender Difference in Treatment and Survival?","status":"COMPLETED","sponsor":"Landspitali University Hospital","startDate":"2008-01-01","conditions":"Acute Myocardial Infarction, Coronary Angiography","enrollment":3257},{"nctId":"NCT04524845","phase":"NA","title":"Study of Biomechanical Parameters of Unloading Braces Used in the Treatment of Knee Osteoarthritis (BIOoSE)","status":"COMPLETED","sponsor":"Thuasne","startDate":"2018-02-01","conditions":"Knee Osteoarthritis","enrollment":13},{"nctId":"NCT04248907","phase":"NA","title":"Transtibial Pin Lock Suspension at Varying Distraction Values Using a Modified Air Bladder Casting System","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2020-01-28","conditions":"Amputation","enrollment":""},{"nctId":"NCT01322568","phase":"","title":"Research on Aging Project in Iceland: Second Stage","status":"COMPLETED","sponsor":"National Institute on Aging (NIA)","startDate":"2003-01-31","conditions":"Atherosclerosis, Osteoporosis, Obesity","enrollment":5764},{"nctId":"NCT03815279","phase":"PHASE2","title":"A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)","status":"ENROLLING_BY_INVITATION","sponsor":"Landspitali University Hospital","startDate":"2019-06-24","conditions":"Multiple Myeloma, Smoldering Multiple Myeloma","enrollment":80},{"nctId":"NCT03943186","phase":"","title":"Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2018-12-13","conditions":"Acute Viral Pharyngitis","enrollment":102},{"nctId":"NCT03901027","phase":"NA","title":"FAM-SOTC Intervention for Families of Children With Chronic Illnesses","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2015-03-01","conditions":"Chronic Illnesses","enrollment":31},{"nctId":"NCT03746145","phase":"NA","title":"A Counter Measure for the Effects of Immune and Microbiome Changes in Environments With Limited ANtigen Diversity (ICELAND-TWO)","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2018-11-15","conditions":"Confinement and Isolation","enrollment":40},{"nctId":"NCT01100853","phase":"PHASE3","title":"Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-05","conditions":"Amphetamine Dependence","enrollment":100},{"nctId":"NCT03269656","phase":"","title":"Age Gene/Environment Susceptibility Reykjavik Study","status":"COMPLETED","sponsor":"Icelandic Heart Association","startDate":"2002-01-01","conditions":"Neoplasms","enrollment":5764},{"nctId":"NCT00083798","phase":"","title":"Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2003-09","conditions":"Sleep Apnea Syndromes, Lung Diseases, Insulin Resistance","enrollment":2843},{"nctId":"NCT02301273","phase":"NA","title":"Being Awake, Upright and Moving as the Basis for Early ICU Physiotherapy","status":"COMPLETED","sponsor":"Landspitali University Hospital","startDate":"2011-11","conditions":"Critical Illness","enrollment":60},{"nctId":"NCT02236455","phase":"NA","title":"Effects of Complementary Therapies Delivered Via Mobile Technologies","status":"COMPLETED","sponsor":"University of San Francisco","startDate":"2012-03","conditions":"Acute Pain, Anxiety, Self Efficacy","enrollment":105},{"nctId":"NCT02233179","phase":"NA","title":"The Association Between Unprotected Standing, Walking and Wound Healing in Diabetes","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2009-06","conditions":"Diabetic Foot","enrollment":49},{"nctId":"NCT01369810","phase":"","title":"Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-07","conditions":"Asthma, Chronic Obstructive Pulmonary Disease","enrollment":20000},{"nctId":"NCT00346008","phase":"","title":"Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members","status":"COMPLETED","sponsor":"Iceland Genomics Corporation","startDate":"2005-10","conditions":"Melanoma (Skin)","enrollment":2500},{"nctId":"NCT01171508","phase":"","title":"Circadian Disturbances After Breast Cancer Surgery","status":"COMPLETED","sponsor":"Melissa Voigt Hansen","startDate":"2011-02","conditions":"Circadian Rhythm Disorders, Anxiety, Breast Cancer","enrollment":12},{"nctId":"NCT01564615","phase":"NA","title":"AgION Catheter for Preventing Catheter-Related Bloodstream Infections","status":"COMPLETED","sponsor":"University of Florence","startDate":"2007-07","conditions":"Catheter-Related Infections","enrollment":86},{"nctId":"NCT01161381","phase":"","title":"Evaluation Of Patients With Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) Based on Nonlinear Analysis Of Respiratory Signals","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2005-11","conditions":"Obstructive Sleep Apnea Syndrome (OSAS)","enrollment":100},{"nctId":"NCT01074879","phase":"NA","title":"Protein Ingestion and Resistance Exercise in Elderly","status":"COMPLETED","sponsor":"University of Iceland","startDate":"2008-08","conditions":"Healthy","enrollment":220}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1375,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Islatravir","MK-8591","islatravir"],"phase":"marketed","status":"active","brandName":"ISL","genericName":"ISL","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ISL is an insulin secretagogue that stimulates pancreatic beta cells to release insulin in response to glucose. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}